Jae-Hoon Yoon
Algemeen Directeur bij RP BIO INC.
Vermogen: 28 M $ op 30-04-2024
Profiel
Jae-Hoon Yoon currently works at RP Bio, lnc., as Co-Chief Executive Officer & Director.
Mr. Yoon also formerly worked at Daewoong Pharmaceutical Co., Ltd., as Vice Chairman & Chief Executive Officer from 1992 to 2010, Daewoong International Corp., as Vice Chairman in 2011, Daewoong Co., Ltd., as Director in 2011, Daewoong Bio, Inc., as Director, R&P Korea Co., Ltd., as Director, and Daewoong Development Co., Ltd., as Director.
Mr. Yoon received his graduate degree from the University of Denver.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
RPBIO INC.
48.27% | 07-10-2022 | 4 183 480 ( 48.27% ) | 28 M $ | 30-04-2024 |
Actieve functies van Jae-Hoon Yoon
| Bedrijven | Functie | Begin |
|---|---|---|
| RP BIO INC. | Algemeen Directeur | - |
Eerdere bekende functies van Jae-Hoon Yoon
| Bedrijven | Functie | Einde |
|---|---|---|
Daewoong Development Co., Ltd.
 Daewoong Development Co., Ltd. Real Estate DevelopmentFinance Part of Daewoong Co., Ltd., Daewoong Development Co., Ltd. is a pharmaceutical company based in Seoul, South Korea. The South Korean company focuses on creating better value for the healthy life of its customers through ceaseless research and development. Daewoong Development Co. provides a comfortable work space where employees can work flexibly and happily. The company also supports education on the local language and culture to help employees grow into talents. The CEO of the company is Jae-Chun Yoon. | Directeur/Bestuurslid | - |
| Daewoong International Corp. | Directeur/Bestuurslid | - |
| R&P Korea Co., Ltd. | Directeur/Bestuurslid | 05-07-2011 |
Daewoong Bio, Inc.
 Daewoong Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Daewoong Bio, Inc. provides pharmaceutical raw materials and intermediate products. Its products include acids, anti-hyperlipidaemic agents, tranquilisers, antiulcerants, antifungals, dietary supplements, anti-thrombotics, cephalosporins, anti-hypertensives, hepatic protectors, penicillin, digestives, diphenyl dimethyl bicarboxylate, amoxicillin, and alibendol. The company was founded on April 15, 1983 and is headquartered in Hwaseong, South Korea. | Directeur/Bestuurslid | - |
| DAEWOONG CO., LTD. | Directeur/Bestuurslid | - |
Opleiding van Jae-Hoon Yoon
| University of Denver | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| DAEWOONG PHARMACEUTICAL CO., LTD | Health Technology |
| DAEWOONG CO., LTD. | Health Technology |
| RP BIO INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Daewoong Bio, Inc.
Daewoong Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Daewoong Bio, Inc. provides pharmaceutical raw materials and intermediate products. Its products include acids, anti-hyperlipidaemic agents, tranquilisers, antiulcerants, antifungals, dietary supplements, anti-thrombotics, cephalosporins, anti-hypertensives, hepatic protectors, penicillin, digestives, diphenyl dimethyl bicarboxylate, amoxicillin, and alibendol. The company was founded on April 15, 1983 and is headquartered in Hwaseong, South Korea. | Commercial Services |
| R&P Korea Co., Ltd. | |
| Daewoong International Corp. | |
Daewoong Development Co., Ltd.
Daewoong Development Co., Ltd. Real Estate DevelopmentFinance Part of Daewoong Co., Ltd., Daewoong Development Co., Ltd. is a pharmaceutical company based in Seoul, South Korea. The South Korean company focuses on creating better value for the healthy life of its customers through ceaseless research and development. Daewoong Development Co. provides a comfortable work space where employees can work flexibly and happily. The company also supports education on the local language and culture to help employees grow into talents. The CEO of the company is Jae-Chun Yoon. | Finance |